JASMINE LEE: Open Payments
NPI 1689320905 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 18 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $235 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $159 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| UCB, Inc. | 2 | $51 |
| SCPHARMACEUTICALS INC. | 2 | $43 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32 |
| Amgen Inc. | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
Products named: LEQVIO, ADVANTIO, Rystiggo, FUROSCIX, ALTRUA 20, WATCHMAN FLX, LifeVest, REPATHA.
Industry payments across TX — which companies pay providers there.
